NO931844L - IMPROVED MATRIX METAL PROTEASE INHIBITORS - Google Patents

IMPROVED MATRIX METAL PROTEASE INHIBITORS

Info

Publication number
NO931844L
NO931844L NO93931844A NO931844A NO931844L NO 931844 L NO931844 L NO 931844L NO 93931844 A NO93931844 A NO 93931844A NO 931844 A NO931844 A NO 931844A NO 931844 L NO931844 L NO 931844L
Authority
NO
Norway
Prior art keywords
alkyl
protease inhibitors
matrix metal
lower alkyl
metal protease
Prior art date
Application number
NO93931844A
Other languages
Norwegian (no)
Other versions
NO931844D0 (en
Inventor
Richard E Galardy
Damian Grobelny
Original Assignee
Glycomed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/615,798 external-priority patent/US5183900A/en
Priority claimed from US07/747,751 external-priority patent/US5239078A/en
Application filed by Glycomed Inc filed Critical Glycomed Inc
Publication of NO931844D0 publication Critical patent/NO931844D0/en
Publication of NO931844L publication Critical patent/NO931844L/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Forbindelser med formler: (1) eller (2) der hver R1 er uavhengig av hverandre H eller alkyl (1-8C) og R2 er alkyl (1-8C) eller der prokslmal R1 og R2 tatt sammen er -(CB2)p¿ hvori p - 3-5; R3 er H eller alkyl (1-4C); R4 er samnensmeltet eller konjugert usubstltuert eller substituert bicykloarylmetylen; n er O, l eller 2; m er O eller 1; og X er OR5 eller NHR5 der R5 er H eller substituert eller usubstltuert alkyl (1-12C), aryl (6-12C), arylalkyl (6- 16C); R7 er lavere alkyl (1-4C) eller en acylgruppe, eller X er et amlnosyreresldu eller amld derav; eller X er residuet av et cykllsk amln eller heterocykllsk amln; Y blir valgt fra gruppen som består av R7ONR6CONR6- , R62NCONOR7-, og R6CONOR7-, der hver R6 er uavhengig av hverandre H eller lavere alkyl (1-4C); R7 er lavere alkyl (1-4C) eller en acylgruppe. der -CONR3- er eventuelt l modifisert Isosterlsk form. Forbindelsene er hemnere av matrlksmetallproteaser .Compounds of formulas: (1) or (2) wherein each R1 is independently H or alkyl (1-8C) and R2 is alkyl (1-8C) or where proxylmal R1 and R2 taken together are - (CB2) p wherein p is 3-5; R 3 is H or alkyl (1-4C); R 4 is fused or conjugated unsubstituted or substituted bicycloarylmethylene; n is 0, 1 or 2; m is 0 or 1; and X is OR5 or NHR5 wherein R5 is H or substituted or unsubstituted alkyl (1-12C), aryl (6-12C), arylalkyl (6-16C); R7 is lower alkyl (1-4C) or an acyl group, or X is an amino acid residue or amide thereof; or X is the residue of a cyclic amine or heterocyclic amine; Y is selected from the group consisting of R7ONR6CONR6-, R62NCONOR7-, and R6CONOR7-, where each R6 is independently H or lower alkyl (1-4C); R7 is lower alkyl (1-4C) or an acyl group. where -CONR3- is optionally in modified Isosteric form. The compounds are inhibitors of metal metal proteases.

NO93931844A 1990-11-21 1993-05-19 IMPROVED MATRIX METAL PROTEASE INHIBITORS NO931844L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/615,798 US5183900A (en) 1990-11-21 1990-11-21 Matrix metalloprotease inhibitors
US07/747,751 US5239078A (en) 1990-11-21 1991-08-20 Matrix metalloprotease inhibitors
PCT/US1991/008722 WO1992009563A1 (en) 1990-11-21 1991-11-21 Improved matrix metalloprotease inhibitors

Publications (2)

Publication Number Publication Date
NO931844D0 NO931844D0 (en) 1993-05-19
NO931844L true NO931844L (en) 1993-07-09

Family

ID=27376843

Family Applications (1)

Application Number Title Priority Date Filing Date
NO93931844A NO931844L (en) 1990-11-21 1993-05-19 IMPROVED MATRIX METAL PROTEASE INHIBITORS

Country Status (1)

Country Link
NO (1) NO931844L (en)

Also Published As

Publication number Publication date
NO931844D0 (en) 1993-05-19

Similar Documents

Publication Publication Date Title
ATE157963T1 (en) IMPROVED MATRIX METAL PROTEASE INHIBITORS
ATE265433T1 (en) IMPROVED MATRIX METAL PROTEASE INHIBITORS
ATE164767T1 (en) TREATMENT FOR TISSUE ULCERATIONS
TW341573B (en) New erythromycin derivatives, their preparation process and their use as medicaments
YU49227B (en) Process for producting n-amino-1-hydroksi-alkil-idene-1,1-bisphosphonic acid
DE60028045D1 (en) NEW AMBERIC DERIVATIVES AS CYSTEINE PROTEASE INHIBITORS
DE50301525D1 (en) Dental materials based on acrylic ester phosphonic acids
ES479931A1 (en) Substituted amino-pyridine derivatives, processes for their preparation and pharmaceutical compositions containing them.
RU94026909A (en) DERIVATIVES OF PIPERAZINCARBONIC ACID, METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL COMPOSITION
NO934628L (en) Retroviral protease inhibitors
ATE137757T1 (en) GEM-DIPHOSPHONIC ACIDS, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
NO995963L (en) Carboxamides useful as 5-HTIF agonists
PH20327A (en) New substituted 1,4-dihydropyridines and pharmaceutical compositions containing the same
CO4970719A1 (en) PIRROLOPYROLONE DERIVATIVES AS LEUCOCITARY ELASTASE INHIBITORS
NO952610L (en) pyridonecarboxylic
NO931844L (en) IMPROVED MATRIX METAL PROTEASE INHIBITORS
TR199800588T1 (en) Herbicide heterocyclic benzisoxazoles and benzisoxazolidinones.
GB1112034A (en) Merocyanine dyes,photographic silver halide emulsions containing them and multilayer photographic elements
ATE3548T1 (en) NEW 5,10-DIHYDRO11H-DIBENZO (B,E)(1,4)DIAZEPIN-11-ONE SUBSTITUTED IN THE 5-POSITION, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICALS CONTAINING THESE COMPOUNDS.
TNSN90153A1 (en) PROCESS FOR THE PREPARATION OF GLYCEROL DERIVATIVES
KR900007371B1 (en) Storage stable aryl-nitrone composition and method thereof
JPS55102556A (en) 22hydroxyynaphthalene derivative and diazo type material containing it
ES8608462A1 (en) Rooperol and its derivatives.
DK0873993T3 (en) New heterocyclic compounds, processes for their preparation and compositions containing them
DK0876393T3 (en) 21- (2-oxo-tetrahydrofuran) -thio-pregnant derivatives, process for their preparation and pharmaceutical compositions containing